A Sensitive HPLC Method for the Determination of Fluoxetine and Norfluoxetine in Human Plasma with Fluorescence Detection
- 1 February 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 27 (1) , 38-43
- https://doi.org/10.1097/00007691-200502000-00009
Abstract
A selective, sensitive, and precise HPLC method for the simultaneous determination of fluoxetine (FL) and its N-demethylated metabolite norfluoxetine (NFL) in human plasma has been developed. Following extraction with n-hexane, FL, NFL, and fluvoxamine (internal standard) were derivatized with 7-chloro-4-nitrobenzofurazan (NBD-Cl) under weakly alkaline conditions. NBD derivatives were extracted with chloroform after acidification and chromatographed on a reversed-phase column with gradient elution using acetonitrile and 0.1 mol/L nitric acid (pH 3) solution. Calibration curves were linear over the range of 1.0-100.0 ng/mL and 0.1-50.0 ng/mL for FL and NFL, respectively, with inter- and intraassay precision given by a relative standard deviation (RSD%) of less than 9.2%. The lower limits of quantification were 1.0 ng/mL for FL and 0.1 ng/mL for NFL. Recoveries of FL and NFL from plasma at three different concentrations were assessed. Average recovery was about 100% for both substances. The assay was applied to pharmacokinetic study in 2 healthy volunteers after a single oral administration of 40 mg of FL.Keywords
This publication has 12 references indexed in Scilit:
- Determination of fluoxetine and norfluoxetine in human plasma by high-performance liquid chromatography with ultraviolet detection in psychiatric patientsJournal of Chromatography B, 2003
- Improved enantioselective assay for the determination of fluoxetine and norfluoxetine enantiomers in human plasma by liquid chromatographyJournal of Chromatography B, 2002
- Liquid chromatography/tandem mass spectrometry for the determination of fluoxetine and its main active metabolite norfluoxetine in human plasma with deuterated fluoxetine as internal standardRapid Communications in Mass Spectrometry, 2002
- Improved HPLC determination of fluoxetine and norfluoxetine in human plasmaChromatographia, 1999
- Determination of fluoxetine and its metabolite norfluoxetine in serum and brain areas using high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- Direct analysis of fluoxetine and norfluoxetine in plasma by gas chromatography with nitrogen-phosphorus detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- Determination of fluoxetine and norfluoxetine in human plasma by capillary gas chromatography with electron-capture detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1993
- Fluoxetine, a selective inhibitor of serotonin uptakeMedicinal Research Reviews, 1991
- The Stereospecific Determination of Fluoxetine and Norfluoxetine Enantiomers in Human Plasma by High-Pressure Liquid Chromatography (HPLC) with Fluorescence DetectionPharmaceutical Research, 1991
- Fluoxetine, a Highly Selective Serotonin Reuptake Inhibitor: A Review of Preclinical StudiesThe British Journal of Psychiatry, 1988